X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (13) 13
cancer (12) 12
index medicus (12) 12
biology (8) 8
chemotherapy (7) 7
tumors (7) 7
female (6) 6
metastasis (6) 6
biochemistry & molecular biology (5) 5
breast cancer (5) 5
chemistry, multidisciplinary (5) 5
oncology (5) 5
primary culture (5) 5
zoledronic acid (5) 5
article (4) 4
bone metastasis (4) 4
breast-cancer (4) 4
care and treatment (4) 4
chemistry (4) 4
denosumab (4) 4
differentiation (4) 4
further section (4) 4
male (4) 4
management (4) 4
metastatic liposarcoma (4) 4
middle aged (4) 4
neoplasms. tumors. oncology. including cancer and carcinogens (4) 4
prognostic-factors (4) 4
sarcoma (4) 4
soft-tissue sarcoma (4) 4
zebrafish (4) 4
aged (3) 3
bone cancer (3) 3
bone neoplasms - secondary (3) 3
breast (3) 3
cancer research (3) 3
cell biology (3) 3
cell culture (3) 3
cell line, tumor (3) 3
classification (3) 3
development and progression (3) 3
diagnosis (3) 3
epirubicin (3) 3
mechanisms (3) 3
medical research (3) 3
medicine, experimental (3) 3
medicine, general & internal (3) 3
multidisciplinary sciences (3) 3
patients (3) 3
research (3) 3
review (3) 3
survival (3) 3
trabectedin (3) 3
1st-line treatment (2) 2
5700 (2) 2
abridged index medicus (2) 2
acid phosphatase (2) 2
adipocytes (2) 2
adjuvant chemotherapy (2) 2
adult (2) 2
aggressive behavior (2) 2
analysis (2) 2
animals (2) 2
antineoplastic agents - pharmacology (2) 2
biomarkers (2) 2
biotechnology & applied microbiology (2) 2
bone health (2) 2
bone metastases (2) 2
bone neoplasms - diagnostic imaging (2) 2
bone-modifying agents (2) 2
breast neoplasms - pathology (2) 2
cd109 (2) 2
cell cycle (2) 2
cell-lines (2) 2
cells (2) 2
clinical case report (2) 2
co-culture (2) 2
coculture techniques (2) 2
collagen scaffolds (2) 2
cultures (2) 2
disease (2) 2
doxorubicin (2) 2
epithelial-mesenchymal transition (2) 2
eribulin (2) 2
everolimus (2) 2
expression (2) 2
filgrastim - therapeutic use (2) 2
granulocyte colony-stimulating factor - therapeutic use (2) 2
hematologic agents - therapeutic use (2) 2
hormone therapy (2) 2
human preclinical model (2) 2
ifosfamide (2) 2
in vitro (2) 2
inhibition (2) 2
italy (2) 2
liposarcoma (2) 2
medical prognosis (2) 2
medicine (2) 2
mesenchyme (2) 2
microenvironment (2) 2
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


International Journal of Molecular Sciences, ISSN 1661-6596, 11/2016, Volume 17, Issue 11, pp. 1827 - 1827
Journal Article
International Journal of Clinical Practice, ISSN 1368-5031, 11/2019, Volume 73, Issue 11, pp. e13404 - n/a
Journal Article
International Journal of Molecular Sciences, ISSN 1661-6596, 08/2017, Volume 18, Issue 8, p. 1655
Although bone metastases represent a major challenge in the natural history of breast cancer (BC), the complex interactions involved have hindered the... 
Mesenchymal stromal cells | Non-canonical osteoclastogenesis | Osteoclasts | Breast cancer | Co-culture | GEFITINIB | METASTASIS | TREFOIL FACTOR-1 | BIOCHEMISTRY & MOLECULAR BIOLOGY | mesenchymal stromal cells | breast cancer | non-canonical osteoclastogenesis | PHASE-II | FOLLOW-UP | co-culture | CHEMISTRY, MULTIDISCIPLINARY | MESENCHYMAL STEM-CELLS | ZOLEDRONIC ACID | osteoclasts | ZD1839 IRESSA | PROSTATE-CANCER | TYROSINE KINASE INHIBITOR | Osteoclasts - pathology | Coculture Techniques | Humans | Mesenchymal Stromal Cells - metabolism | Monocytes - metabolism | Neoplasm Proteins - antagonists & inhibitors | Neoplasm Proteins - metabolism | Breast Neoplasms - drug therapy | Osteoclasts - metabolism | Breast Neoplasms - metabolism | Neoplasm Metastasis | Receptor, Epidermal Growth Factor - metabolism | Signal Transduction - drug effects | Breast Neoplasms - pathology | Cell Communication - drug effects | Monocytes - pathology | Cell Line, Tumor | Receptor, Epidermal Growth Factor - antagonists & inhibitors | Female | Mesenchymal Stromal Cells - pathology | Quinazolines - pharmacology | Osteoprogenitor cells | Cell culture | Mesenchyme | Crosstalk | Metastasis | Metastases | Tissue | Biomedical materials | Peripheral blood mononuclear cells | Biocompatibility | Bones | Inhibition | Pretreatment | Conditioning | Gefitinib | Fibroblast growth factor 2 | Epidermal growth factor receptors | Nuclear electric power generation | Osteoclastogenesis | Monocytes | Bone cancer | Stromal cells | Stem cells | Cells (biology) | Breast | Acid phosphatase (tartrate-resistant) | Differentiation | In vitro methods and tests | Cancer | Tumors
Journal Article
International Journal of Molecular Sciences, ISSN 1661-6596, 12/2017, Volume 18, Issue 12, p. 2662
Undifferentiated pleomorphic sarcoma (UPS) is an aggressive mesenchymal neoplasm with no specific line of differentiation. Eribulin, a novel synthetic... 
Chemotherapy | Eribulin | Primary culture | Malignant fibrous histiocytoma | Drug resistance | EMT | Undifferentiated pleomorphic sarcoma | malignant fibrous histiocytoma | HALICHONDRIN-B | CLINICAL-TRIAL | primary culture | BIOCHEMISTRY & MOLECULAR BIOLOGY | eribulin | IN-SITU HYBRIDIZATION | CELL-LINES | chemotherapy | CHEMISTRY, MULTIDISCIPLINARY | undifferentiated pleomorphic sarcoma | BREAST-CANCER | METASTATIC LIPOSARCOMA | RETROPERITONEAL SARCOMA | drug resistance | ERIBULIN MESYLATE | SOFT-TISSUE SARCOMA | Humans | Epithelial-Mesenchymal Transition - drug effects | Ketones - administration & dosage | Male | Tetrahydroisoquinolines - administration & dosage | Antineoplastic Agents - administration & dosage | Sarcoma - drug therapy | Sarcoma - pathology | Trabectedin | Patients | Drug Resistance, Neoplasm - genetics | Dioxoles - administration & dosage | Apoptosis Regulatory Proteins - genetics | Cell Cycle Checkpoints - genetics | Aged | Biomarkers, Tumor - genetics | Gene Expression Regulation, Neoplastic - drug effects | Primary Cell Culture | Sarcoma - genetics | Furans - administration & dosage | Cell culture | Sensitivity analysis | Aggressive behavior | Mesenchyme | Sarcoma | Genes | Chemoresistance | Pharmacology | Gene expression | Drug development | Anticancer properties | Proteins | Depolymerization | Antitumor agents | Cell cycle | Antitumor activity | Molecular biology | Cancer | Apoptosis | Tumors
Journal Article
Disease markers, ISSN 0278-0240, 2018, Volume 2018, pp. 6878409 - 8
There is a growing need for more accurate biomarkers to facilitate the diagnosis and prognosis of patients with grade (G) 3 neuroendocrine carcinomas (NECs).... 
Nuclear medicine | Evaluation | Medical imaging | Carcinoma | Peptides | Positron emission | Metabolism | Tissues | Patients | Chemotherapy | Daxx protein | Computed tomography | Correlation analysis | Medical prognosis | Morphology | Classification | Tomography | Biomarkers | Mutation | Positron emission tomography | Movement disorders | Neuroendocrine tumors | Cancer
Journal Article
Supportive Care in Cancer, ISSN 0941-4355, 1/2017, Volume 25, Issue 1, pp. 111 - 117
Journal Article
Therapeutic Advances in Medical Oncology, ISSN 1758-8340, 12/2017, Volume 9, Issue 12, pp. 755 - 767
Background: Myxofibrosarcoma (MFS), formerly considered as a myxoid variant of malignant fibrous histiocytoma, is the most common sarcoma of the extremities in... 
TGF-β | high-grade myxofibrosarcoma | primary culture | chemotherapy | CD109 | PROGNOSTIC-FACTORS | PHASE-II | HIGH-DOSE IFOSFAMIDE | BREAST-CANCER | TGF-beta | METASTATIC LIPOSARCOMA | ONCOLOGY | TRABECTEDIN | CD109 EXPRESSION | SOFT-TISSUE SARCOMA | Case Series
Journal Article